(Q40789277)

English

Comparison of piperacillin alone versus piperacillin plus tobramycin for treatment of respiratory infections in children with cystic fibrosis

scientific article published on January 1, 1988

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

23 September 2017

Comparison of piperacillin alone versus piperacillin plus tobramycin for treatment of respiratory infections in children with cystic fibrosis (English)

1 reference

10.1002/PPUL.1950040403

https://api.crossref.org/works/10.1002/PPUL.1950040403

4 January 2023

cystic fibrosis

0 references

author name string

J. M. McCarty

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A3393383

4 January 2023

S. J. Tilden

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A3393383

4 January 2023

P. Black

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A3393383

4 January 2023

J. C. Craft

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A3393383

4 January 2023

J. Blumer

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A3393383

4 January 2023

W. Waring

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A3393383

4 January 2023

N. A. Halsey

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A3393383

4 January 2023

language of work or name

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=3393383

4 January 2023

publication date

1 January 1988

1 reference

Europe PubMed Central

23 September 2017

full work available at URL

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fppul.1950040403

1 reference

10.1002/PPUL.1950040403

https://api.crossref.org/works/10.1002/PPUL.1950040403

4 January 2023

https://onlinelibrary.wiley.com/doi/full/10.1002/ppul.1950040403

1 reference

10.1002/PPUL.1950040403

https://api.crossref.org/works/10.1002/PPUL.1950040403

4 January 2023

Pediatric Pulmonology

1 reference

Europe PubMed Central

23 September 2017

4

1 reference

Europe PubMed Central

23 September 2017

201-204

1 reference

Europe PubMed Central

23 September 2017

4

1 reference

Europe PubMed Central

23 September 2017

Piperacillin: In Vitro Evaluation

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.1950040403

21 January 2018

In Vitro Activity of Piperacillin Compared with That of Carbenicillin, Ticarcillin, Ampicillin, Cephalothin, and Cefamandole Against Pseudomonas aeruginosa and Enterobacteriaceae

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.1950040403

21 January 2018

Clinical and Bacteriological Responses to Three Antibiotic Regimens for Acute Exacerbations of Cystic Fibrosis: Tlcarcillln-Tobramycin, Azlocillin-Tobramycin, and Azlocillin-Placebo

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.1950040403

21 January 2018

Piperacillin pharmacokinetics in pediatric patients

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.1950040403

21 January 2018

The pathogenesis and treatment of pulmonary infections in patients with cystic fibrosis

1

1 reference

10.1002/PPUL.1950040403

https://api.crossref.org/works/10.1002/PPUL.1950040403

4 January 2023

Is anti-Pseudomonas therapy warranted in acute respiratory exacerbations in children with cystic fibrosis?

2

1 reference

10.1002/PPUL.1950040403

https://api.crossref.org/works/10.1002/PPUL.1950040403

4 January 2023

Pharmacokinetics of intravenously administered piperacillin in preadolescent children

10

1 reference

10.1002/PPUL.1950040403

https://api.crossref.org/works/10.1002/PPUL.1950040403

4 January 2023

Piperacillin therapy for serious bacterial infections.

11

1 reference

10.1002/PPUL.1950040403

https://api.crossref.org/works/10.1002/PPUL.1950040403

4 January 2023

Adverse reactions to piperacillin in cystic fibrosis.

12

1 reference

10.1002/PPUL.1950040403

https://api.crossref.org/works/10.1002/PPUL.1950040403

4 January 2023

Adverse reactions to piperacillin in patients with cystic fibrosis

13

1 reference

10.1002/PPUL.1950040403

https://api.crossref.org/works/10.1002/PPUL.1950040403

4 January 2023

Adverse reactions to piperacillin in cystic fibrosis

14

1 reference

10.1002/PPUL.1950040403

https://api.crossref.org/works/10.1002/PPUL.1950040403

4 January 2023

Comparison of piperacillin vs. ticarcillin plus tobramycin in the treatment of acute pulmonary exacerbations of cystic fibrosis

15

1 reference

10.1002/PPUL.1950040403

https://api.crossref.org/works/10.1002/PPUL.1950040403

4 January 2023

Identifiers

10.1002/PPUL.1950040403

1 reference

Europe PubMed Central

23 September 2017

1 reference

Europe PubMed Central

23 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40789277&oldid=1802986242"